People
Marisa A. Sotomayor is a partner in the Finance and Restructuring group based in the Firm's New York office. Marisa is widely recognized for her work in debt financings and other complex corporate finance matters. Marisa's clients say “she’s super smart and easy to work with – she’s great”; “Marisa is fantastic – she is technically excellent and also very client focused” (Chambers USA, 2023); and "her tenacity and can-do attitude are not only valued but a comfort to us as a client" (Chambers USA, 2025). She regularly represents investment and commercial banks, alternative lenders and private credit providers, and private equity sponsors and corporate borrowers in a wide range of complex large-cap and middle-market transactions. Marisa also has significant experience in restructurings, intercreditor matters, and syndicated project financings. Legal500 has named Marisa a "Leading Partner" for Direct Lending and Private Credit, and she was named a 2026 Leading Dealmaker in America by Lawdragon. Marisa is a Fellow of the American College of Commercial Finance Lawyers.
Marisa deftly handles sponsored and non-sponsored / public deals, including leveraged cash flow and asset-based credits, acquisition financings, syndicated transactions, club and bilateral deals, unitranche loans, cross-border loans, recurring revenue loans, first / second lien and multitranche loans, refinancings, and dividend recapitalizations. Active in the Firm and the advancement of the legal profession generally, Marisa co-chairs the Secured Transactions subcommittee of the American Bar Association’s Business Law Section and is a member of the editorial board of Business Law Today.
J.D., Fordham University School of Law
M.P.A., SUNY at Albany
B.A., SUNY at Albany, summa cum laude, Phi Beta Kappa
New York
American Bar Association
American College of Commercial Finance Lawyers
Spanish
August 7, 2025
K&S advises Oxford Biomedica PLC on its $125M secured loan facility provided by Oaktree Capital Management
August 1, 2025
King & Spalding advises Oxford Biomedica PLC on $125m secured financing package
June 11, 2025
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2025 Guide
Represented a leading commercial bank, as a lender and joint lead arranger, in connection with the financing of part of the $7 billion acquisition of Focus Financial by Clayton, Dubilier & Rice.
Represented Barclays, as administrative agent and a lender, and the other lenders in connection with a $2.575 billion senior secured term loan facility for Inspire Brands, a Roark Capital portfolio company and franchisor of Dunkin’, Arby’s, Buffalo Wild Wings, Sonic, Jimmy John’s and Baskin-Robbins.
Represented a leading commercial bank, as a lender, in connection with a $120 million incremental revolving credit facility for a preeminent global consumer intelligence company, in addition to an existing $950 million term loan facility, €545 million term loan facility, C$128 million term loan facility and approx. $508 million revolving credit facility.
See more
March 17, 2025
Accounting Firm LBOs: Financing Considerations for Lenders
March 13, 2024
The J. Crew Legacy in Secured Lending: Consider a ‘Tailored’ Approach
August 7, 2025
K&S advises Oxford Biomedica PLC on its $125M secured loan facility provided by Oaktree Capital Management
August 1, 2025
King & Spalding advises Oxford Biomedica PLC on $125m secured financing package
June 11, 2025
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2025 Guide
Represented a leading commercial bank, as a lender and joint lead arranger, in connection with the financing of part of the $7 billion acquisition of Focus Financial by Clayton, Dubilier & Rice.
Represented Barclays, as administrative agent and a lender, and the other lenders in connection with a $2.575 billion senior secured term loan facility for Inspire Brands, a Roark Capital portfolio company and franchisor of Dunkin’, Arby’s, Buffalo Wild Wings, Sonic, Jimmy John’s and Baskin-Robbins.
Represented a leading commercial bank, as a lender, in connection with a $120 million incremental revolving credit facility for a preeminent global consumer intelligence company, in addition to an existing $950 million term loan facility, €545 million term loan facility, C$128 million term loan facility and approx. $508 million revolving credit facility.
See more
March 17, 2025
Accounting Firm LBOs: Financing Considerations for Lenders
March 13, 2024
The J. Crew Legacy in Secured Lending: Consider a ‘Tailored’ Approach
August 7, 2025
K&S advises Oxford Biomedica PLC on its $125M secured loan facility provided by Oaktree Capital Management
August 1, 2025
King & Spalding advises Oxford Biomedica PLC on $125m secured financing package
June 11, 2025
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2025 Guide
J.D., Fordham University School of Law
M.P.A., SUNY at Albany
B.A., SUNY at Albany, summa cum laude, Phi Beta Kappa
New York
American Bar Association
American College of Commercial Finance Lawyers
Spanish